Clear Search

Showing 1 result for “Di Giuseppe D” published 2022.

October 2022

JAK阻害薬と他の治療薬における静脈血栓症: 関節リウマチ患者におけるスウェーデンの安全性比較研究

Ann Rheum Dis. 2022. doi: 10.1136/ard-2022-223050

Nationwide register-based study in Sweden finds that patients with RA treated with JAKinibs in routine clinical practice are at increased risk of venous thromboembolism (VTE), compared with those treated with bDMARDs, an increase numerically confined to pulmonary embolism.